BioThrust is a global accelerator for accessible cell therapies through excellence in bioreactor technologies and process services. The company develops a next-generation bioreactor platform to revolutionize the production of modern biopharmaceutical products such as cell therapies.

The core innovation of BioThrust’s novel bioreactor is the Membrane Stirrer technology—the first worldwide to achieve bubble-free aeration. For the first time, the BioThrust system can produce pluripotent stem cells at industrial volumes of 50-200 liters. It enables the first-ever transfer of novel processes to scalable, efficient bioreactors, including the production of organoids. In addition with the unique in-situ perfusion system a versatile process intensification/ enabling tool for all working in sensitive cell cultivation (proliferation & differentiation).

BioThrust offers complete single-use bioreactor systems to customers, both as standalone benchtop systems and for use in an incubator. In addition, process transfer services to support scale up or technology transfer are offered.